DIPENTUM Drug Patent Profile

✉ Email this page to a colleague

When do Dipentum patents expire, and when can generic versions of Dipentum launch?

Dipentum is a drug marketed by Mylan Spclt Viatris and is included in one NDA.

The generic ingredient in DIPENTUM is olsalazine sodium. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the olsalazine sodium profile page.

Summary for DIPENTUM

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	150
Patent Applications:	4,077
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for DIPENTUM
What excipients (inactive ingredients) are in DIPENTUM?	DIPENTUM excipients list
DailyMed Link:	DIPENTUM at DailyMed

Drug patent expirations by year for DIPENTUM

Pharmacology for DIPENTUM

Drug Class	Aminosalicylate

Anatomical Therapeutic Chemical (ATC) Classes for DIPENTUM

A07EC	Aminosalicylic acid and similar agents
A07E	INTESTINAL ANTIINFLAMMATORY AGENTS
A07	ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
A	Alimentary tract and metabolism

US Patents and Regulatory Information for DIPENTUM

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mylan Spclt Viatris	DIPENTUM	olsalazine sodium	CAPSULE;ORAL	019715-001	Jul 31, 1990		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for DIPENTUM

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Mylan Spclt Viatris	DIPENTUM	olsalazine sodium	CAPSULE;ORAL	019715-001	Jul 31, 1990	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for DIPENTUM

See the table below for patents covering DIPENTUM around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
European Patent Office	0036637	USE OF 3,3'-AZO-BIS-(6-HYDROXY BENZOIC ACID) AS A DRUG AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME	⤷ Try a Trial
Germany	3161216		⤷ Try a Trial
Netherlands	930101		⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Summary for DIPENTUM

Pharmacology for DIPENTUM

Anatomical Therapeutic Chemical (ATC) Classes for DIPENTUM

Make Better Decisions: Try a trial or see plans & pricing